You are here:Home-Chemical Inhibitors & Agonists-Membrane Transporter/Ion Channel-P-glycoprotein (P-gp)-Dofequidar
Dofequidar

Chemical Structure : Dofequidar

CAS No.: 129716-58-1

Dofequidar (MS-209, MS209)

Catalog No.: PC-45136Not For Human Use, Lab Use Only.

Dofequidar (MS-209) is an orally active quinoline compound that can reverse P-glycoprotein (P-gp)-mediated MDR.

Packing Price Stock Quantity
10 mg $138 In stock
25 mg $238 In stock
50 mg $398 In stock
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Dofequidar (MS-209) is an orally active quinoline compound that can reverse P-glycoprotein (P-gp)-mediated MDR.
Dofequidar completely reverses resistance against vincristine in vitro in multidrug-resistant variants of mouse leukemia P388 cells and human leukemia K562 cells at 1-10 uM.
Dofequidar greatly reduces the SP-derived tumor growth in vivo combined with CPT-11.

Physicochemical Properties

M.Wt 481.5854
Formula C30H31N3O3
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

Ethanone, 1-[4-[2-hydroxy-3-(5-quinolinyloxy)propyl]-1-piperazinyl]-2,2-diphenyl-

References

1. Nakanishi O, et al. Oncol Res. 1997;9(2):61-9.

2. Sato W, et al. Cancer Chemother Pharmacol. 1995;35(4):271-7.

3. Katayama R, et al. Cancer Sci. 2009 Nov;100(11):2060-8.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: